Oncolytic virus
Oncolytic virus is a type of virus that specifically infects and kills cancer cells. Oncolytic viruses are thought to work by selectively replicating in and killing cancer cells, thereby releasing a progeny virus that can infect other similar cells. This is in contrast to traditional therapies, such as chemotherapy and radiation therapy, which destroy both cancerous and healthy cells.
History
The concept of oncolytic viruses dates back to the 19th century, when doctors noticed that some cancer patients experienced remission after suffering from viral infections. However, it wasn't until the late 20th century that scientists began to understand the mechanisms by which viruses could be used to target cancer cells.
Mechanism of Action
Oncolytic viruses are able to selectively infect and kill cancer cells due to differences in the cellular machinery of normal and cancerous cells. These differences allow the virus to replicate in cancer cells, but not in normal cells. Once the virus has replicated, it causes the cancer cell to burst, releasing the new viruses to infect other cancer cells.
Types of Oncolytic Viruses
There are several types of oncolytic viruses currently being researched, including adenoviruses, herpes simplex viruses, and vesicular stomatitis viruses. Each of these viruses has unique properties that make them suitable for targeting certain types of cancer.
Clinical Trials
Several oncolytic viruses are currently in clinical trials for the treatment of various types of cancer. These trials are designed to test the safety and efficacy of the viruses, as well as to determine the optimal dosage and delivery method.
Future Directions
Research into oncolytic viruses is ongoing, with scientists continually discovering new ways to enhance the selectivity and potency of these viruses. Future directions for this field include the development of combination therapies, in which oncolytic viruses are used in conjunction with other treatments, such as chemotherapy or radiation therapy.
See Also
References
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



